Symmetry Medical (NYSE:SMA) put some red ink into its ledgers during the 3rd quarter as it struggled to integrate a pair of acquisitions and recovered from a fire in a British plant that destroyed part of the facility.
Q3
Coloplast gains on Q4, FY2013 results
ArthroCare misses the mark with Q3 earnings
ArthroCare (NSDQ:ARTC) missed Wall Street’s forecast for its 3rd-quarter earnings, sending share prices down nearly 3% this week.
Masimo beats The Street, raises outlook, shares slip anyway
Globus Medical gains on Q3 results, raised earnings guidance
Globus Medical (NYSE:GMED) shares gained this week after the medical device company reported strong 3rd-quarter results ahead of Wall Street’s expectations and raised its earnings outlook for the rest of the year.
Cardiovascular Systems hits 52-week high on Q1 results
Cardiovascular Systems (NSDQ:CSII) shares posted a 52-week high just after noon today as investors reacted to strong fiscal 1st-quarter results.
Thoratec gains on Q3 earnings beat
Smith & Nephew names new chairman, posts Q3 profit slip
Smith & Nephew (FTSE:SN, NYSE:SNN) tapped Roberto Quarta to be its new chairman and said its 3rd-quarter profits slid nearly 8%.
AtriCure gains on surging Q3 sales, raised outlook
NuVasive boosts outlook after Q3 profits more than triple
NuVasive Inc. (NSDQ:NUVA) could be a big gainer today after the medical device company said yesterday that it more than tripled its 3rd-quarter profits, bested Wall Street’s earnings expectations and boosted its sales and earnings outlook for the balance of 2013.